Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration

Clin Genet. 2004 Jun;65(6):483-6. doi: 10.1111/j.1399-0004.2004.00250.x.


Plasma total homocysteine (tHcy) concentration, an independent risk factor of atherosclerosis, has numerous genetic and environmental determinants. While the thermolabile polymorphism in MTHFR encoding methylenetetrahydrofolate reductase is the best-studied genetic factor associated with variation in plasma tHCy, other candidate genes are being evaluated. Recently, we discovered that cystathioninuria was caused by mutations in the CTH gene encoding cystathionine gamma-lyase, an enzyme that converts cystathionine to cysteine in the trans-sulfuration pathway. We also identified a common single nucleotide polymorphism (SNP), namely c.1364G>T (S403I) in exon 12 of CTH. In the current analysis, we studied the association of genotypes of this SNP with plasma tHcy concentrations in 496 Caucasian subjects. CTH 1364T/T homozygotes had significantly higher mean plasma tHcy concentration than subjects with other genotypes, and the effect sizes of CTH and MTHFR genotypes were similar. The findings suggest that common variation in CTH may be a determinant of plasma tHcy concentrations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution / genetics
  • Carotid Stenosis / metabolism
  • Cystathionine gamma-Lyase / genetics*
  • Female
  • Homocysteine / blood*
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*


  • Homocysteine
  • Cystathionine gamma-Lyase